BioXtrim Contact Eyal Geron

One Page overview Email eyal@bioxtrim.com Mobile +972.544.274627

Industry – Medical device
No. of employees – 5
Current Investors – Nini Bluman, Hanan Gothait,
Amount Sought for what round: a)750K b)$3.5M
Current Revenue - NA
Company Launch Date – 2004
Prototype - Yes + Clinical Trails
Previous Outer Investments – None
Valuation - TBD
Use Of Funds – R&D, Marketing, MFG

The Mission Shortening dramatically the neuro rehabilitation therapy process and changing the
economic model and structure of the industry. The company has probably the only
proven technology today that reduces the total expenses on rehab therapy by 50%-70%,
Time and Money wise
The Product The system enables the patient to perform a repetitive practice of various functional
motor tasks, with natural visio-feedback, screen-feedback or a virtual reality feedback, as
the robotic arm engaged to patient extremity. During a repetitive practice, the system
applies environmental forces to the trained extremity, to extreme the errors.
Clinical Trails 10 subjects - inpatients & long post-stroke outpatient Treatments length & frequency:
2 types exercise, 5 min exercise, 3 times a week, Shorten recovery to healthy results by
more than 50%, Excellence in patient reaction to method & system, No regression.

The Business The business plan market share expectations remain conservative. The first year of
Model activity has been designated for conducting the first marketing module and building the
distribution channels mainly in USA. In the first year, we predict selling & leasing the
first units. In following two years we believe we can install another +100 units, and lease
200 more. The accumulate revenues projected from sales & services are showing a
positive ROI after 2 years.

IP Status The technology is protected by a broad global patent pending, in an advanced national
stage phase, with a positive response from the PCT.

The Market The spending on neuro rehab is estimated at $400B in the western world, $150B in the
USA alone. There are 1.8M injuries annually (mainly stroke), 75% of them will have to
enter rehab movement rehabilitation

The There is currently no direct competitor.

Competition • Trend - Robot-assisted therapy combined with virtual reality
• Therapy method - Automation of regular therapy
• Enable an intensive regular therapy to stimulate recovery
• Traditional non automated treatment.
Management
Eyal Geron, CEO Many years of experience in the hi-tech industry as business
manager of Tadiran Communication, CEO of ISFAR IT (Sony
Israel,), Ankor (Storage), Comsec (Storage), EIM (Comp,),
Surgivision (medical devices) and Bspot (Comm)
Nini Bluman, BSc-M.Eng, Exp in R&D management, medical & Robotics
Founder products development.

Hanan Gothait , BSc-M.Eng, a serial successful business development founder:

Founder Director “Idanit”(“Scitex vision”); “Objet” & “Xjet”
Prof. Avi Ohry, M.D, An expert & director of rehab medicine units, holding
Founder Medical several relevant positions & known by world reputation.
Director
Alon Goldstein, BSc-E.Eng, Exp in medical & Robotics products
Assaf Morag MD, MBA – Founded ‘Pegasus Medical’ and RelayHealth’ both
sold to McKesson. Large company experience McKesson,
Elsevier & Intel

Only Page Sep 2008